1-9 of 9
Alicia Arenas
Close
Sort by
Journal Articles

Inhibition of the Hedgehog Pathway Decreases the Quiescent CD34+CD38- Population in Acute Myeloid Leukemia

Alicia Arenas, Daniel Lainez, Cristina Serrano del Castillo, MD, Rocio N Salgado, PhD, Carlos Blas, MD, Mireia Atance, Raul Cordoba, MD PhD, Pilar Llamas, MD PhD, Juan Manuel Alonso Dominguez, MD PhD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1509.
https://doi.org/10.1182/blood-2018-99-118636
Published: 2018
Journal Articles

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Juan Manuel Alonso Dominguez, MD PhD MSc, Alicia Arenas, PhD, Pilar Llamas, MDPhD, Diego Velasco, Aránzazu García-Raso, PhD, Jose Luis Lopez Lorenzo, MD, Mireia Atance, Rocio N Salgado, PhD, Joaquin Martinez Lopez, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5245.
https://doi.org/10.1182/blood.V130.Suppl_1.5245.5245
Published: 2017
Journal Articles

Altered Carbonylation Pattern in Myelodisplastic Syndromes

María Linares, PhD, Alba Rodríguez-García, Keina Quiroz, Maria Teresa Cedena, Alicia Arenas, PhD, Maria Luz Morales, Laura Sánchez-Vega, Rosa Ayala, Jose Manuel Bautista, Joaquín Martínez
Journal: Blood
Blood (2017) 130 (Supplement 1): 5302.
https://doi.org/10.1182/blood.V130.Suppl_1.5302.5302
Published: 2017
Journal Articles

Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

Joaquín Martínez-López, MD PhD, María Linares, Maria Luz Morales, Alicia Arenas, Ivana Zagorac, Rosa M. Ayala, MD PhD, Nerea Castro, Inmaculada Rapado, PhD, Miguel Quintela-Fandino
Journal: Blood
Blood (2016) 128 (22): 1581.
https://doi.org/10.1182/blood.V128.22.1581.1581
Published: 2016
Journal Articles

Nilotinib Plus Ruxolitinib Produces Anti-Fibrotic Effect

Alicia Arenas, Rosa M. Ayala, MD PhD, María Linares, PhD, Joaquín Martínez-López, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5497.
https://doi.org/10.1182/blood.V128.22.5497.5497
Published: 2016
Journal Articles

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

Juan Manuel Alonso-Dominguez, MD, Felipe Casado, MariaTeresa Gómez Casares, MDPhD, Ismael Buno, Francisca Ferrer-Marin, Eduardo Anguita, MD PhD, Alicia Arenas, Rafael Del Orbe, MD, Rosa M. Ayala, MD PhD, Pilar Llamas, MD, Pedro Sanchez-Godoy, MD, Carmen Burgaleta, MD, Valentín García-Gutierrez, Juan Luis Steegmann, MD PhD, Joaquin Martinez-Lopez
Journal: Blood
Blood (2015) 126 (23): 2791.
https://doi.org/10.1182/blood.V126.23.2791.2791
Published: 2015
Journal Articles

Ruxolitinib in Combination with Nilotinib and Prednisolone, a New Synergistic Approach to Treat Myelofibrosis

Alicia Arenas, Pilar Hernandez-Campo, PhD, Julian Gorrochategui, Daniel Primo, PhD, Rosa M. Ayala, MD PhD, Blanca Ferrer-Lores, MD, Joan Ballesteros, PhD, Joaquin Martinez-Lopez, MD PhD
Journal: Blood
Blood (2014) 124 (21): 903.
https://doi.org/10.1182/blood.V124.21.903.903
Published: 2014
Journal Articles

High Throughput Screening, With a Flow Cytometry Automated Platform (Ex vivo Biotech), To Identify Potential Combination Partners, For The JAK 2 Inhibitor Ruxolitinib

Alicia Arenas, Pilar Hernandez-Campo, Daniel Primo, Santiago Barrio, PhD, Rosa M. Ayala, MD, PhD, Joan Ballesteros, Joaquín Martínez-López, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2534.
https://doi.org/10.1182/blood.V122.21.2534.2534
Published: 2013
Journal Articles

Inhibition of Related JAK/STAT Pathways with Molecular Targeted Drugs Shows Strong Synergy with Ruxolitinib in Chronic Myeloproliferative Neoplasms

Santiago Barrio, Miguel Gallardo, Alicia Arenas, Rosa M. Ayala, MD, PhD, Inmaculada Rapado, Daniel Rueda, PhD, Ana Jimenez, Enriqueta Albizua, Carmen Burgaleta, Florinda Gilsanz, MD, PhD, Joaquin Martinez, MD
Journal: Blood
Blood (2012) 120 (21): 5054.
https://doi.org/10.1182/blood.V120.21.5054.5054
Published: 2012